Insider Purchase: Director at $HRTG Buys 2,500 Shares

Director Paul L Whiting purchased 2,500 shares of $HRTG on 06-09-2025 for approximately $55,900, increasing their holdings by 3.1% to a total of 82,076 shares; overall, $HRTG insiders have engaged in 4 purchases and 3 sales in the last six months. Recent institutional activity shows mixed sentiment, with firms like ARROWSTREET CAPITAL and QUARTZ PARTNERS increasing their positions significantly in Q1 2025, while INVESCO LTD. and JACOBS LEVY EQUITY MANAGEMENT reduced theirs.

Analysis

A recent SEC filing indicates that Paul L Whiting, a director at $HRTG, acquired 2,500 shares on June 9, 2025, for an estimated $55,900, thereby increasing his holdings in this stock class by approximately 3.1% to a total of 82,076 shares. This transaction is part of a broader insider trading pattern at $HRTG, which has seen 7 open market trades over the past six months, comprising 4 purchases and 3 sales. Notably, executive purchases include Paul L Whiting's two acquisitions totaling 12,500 shares for $189,400, CFO Kirk Lusk's purchase of 6,000 shares for $83,100, and CEO Ernie J Garateix's acquisition of 5,000 shares for $63,850, suggesting positive sentiment from key leadership. Conversely, insider sales include Vijay Walvekar disposing of 42,100 shares for an estimated $979,675 and Panagiotis Apostolou selling 25,000 shares for approximately $635,000. Institutional activity for $HRTG presents a mixed picture from the most recent quarter, with 66 institutional investors adding shares and 82 decreasing their positions. Significant Q1 2025 institutional inflows feature Arrowstreet Capital adding 208,221 shares (+203.9%) and Quartz Partners, LLC initiating a substantial position with 144,580 shares. In contrast, Invesco Ltd. reduced its stake by 212,300 shares (-22.5%), Jacobs Levy Equity Management cut its holding by 141,542 shares (-22.0%), and Kennedy Capital Management LLC fully exited its 104,296 share position in Q4 2024. The per-ticker sentiment for $HRTG is mildly positive at 0.2, reflecting this nuanced activity.

Key Decisions for Investors

• Recent insider purchases by $HRTG's director, CEO, and CFO offer a positive signal regarding management's conviction, which investors should note as a potential bullish indicator.
• Investors should carefully weigh these insider buys against the larger aggregate value of recent insider sales and the mixed institutional sentiment, highlighted by Arrowstreet Capital's significant additions versus Invesco's substantial reductions, suggesting a need for further due diligence.
• It is advisable to monitor upcoming Form 4 filings for continued insider trading patterns and Q2 2025 institutional holdings data to better assess if a clearer directional bias emerges among these key market participants before adjusting portfolio allocations.